Compendium of Cancer Genome Aberrations

Changes

HAEM5:Volunteer Assignments and Opportunities (view source)

Revision as of 11:21, 23 December 2023

321 bytes added ,  11:21, 23 December 2023
no edit summary
Line 1,640: Line 1,640:  
|In Situ Mantle Cell Neoplasia
 
|In Situ Mantle Cell Neoplasia
 
|Rina Kansal, MD; Versiti Blood Center of Wisconsin
 
|Rina Kansal, MD; Versiti Blood Center of Wisconsin
−
|
+
|Complete
−
|
+
|7/26/2022
 
|
 
|
 
|-
 
|-
Line 1,660: Line 1,660:  
|Target completion date 8/15/20
 
|Target completion date 8/15/20
 
|-
 
|-
−
|Leukaemic non-nodal mantle cell lymphoma
+
|[[HAEM5:Leukaemic non-nodal mantle cell lymphoma|Leukaemic non-nodal mantle cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,676: Line 1,676:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Transformations of indolent B-cell lymphomas
+
|[[HAEM5:Transformations of indolent B-cell lymphomas|Transformations of indolent B-cell lymphomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,685: Line 1,685:  
|SG
 
|SG
 
|
 
|
−
|
+
|Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
−
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Diffuse large B-cell lymphoma, NOS||Disease|| || || || || ||GC|| ||
 
|Diffuse large B-cell lymphoma, NOS||Disease|| || || || || ||GC|| ||
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/13977"